JP2002522355A5 - - Google Patents

Download PDF

Info

Publication number
JP2002522355A5
JP2002522355A5 JP2000531179A JP2000531179A JP2002522355A5 JP 2002522355 A5 JP2002522355 A5 JP 2002522355A5 JP 2000531179 A JP2000531179 A JP 2000531179A JP 2000531179 A JP2000531179 A JP 2000531179A JP 2002522355 A5 JP2002522355 A5 JP 2002522355A5
Authority
JP
Japan
Prior art keywords
thr
leu
ser
asn
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000531179A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002522355A (ja
JP4372345B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/002603 external-priority patent/WO1999040928A1/en
Publication of JP2002522355A publication Critical patent/JP2002522355A/ja
Publication of JP2002522355A5 publication Critical patent/JP2002522355A5/ja
Application granted granted Critical
Publication of JP4372345B2 publication Critical patent/JP4372345B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000531179A 1998-02-13 1999-02-05 新規な混合アミリン活性化合物 Expired - Fee Related JP4372345B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7474698P 1998-02-13 1998-02-13
US60/074,746 1998-02-13
PCT/US1999/002603 WO1999040928A1 (en) 1998-02-13 1999-02-05 Novel mixed amylin activity compounds

Publications (3)

Publication Number Publication Date
JP2002522355A JP2002522355A (ja) 2002-07-23
JP2002522355A5 true JP2002522355A5 (cg-RX-API-DMAC7.html) 2006-03-09
JP4372345B2 JP4372345B2 (ja) 2009-11-25

Family

ID=22121450

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000531179A Expired - Fee Related JP4372345B2 (ja) 1998-02-13 1999-02-05 新規な混合アミリン活性化合物

Country Status (8)

Country Link
EP (1) EP1053001B1 (cg-RX-API-DMAC7.html)
JP (1) JP4372345B2 (cg-RX-API-DMAC7.html)
AT (1) ATE491723T1 (cg-RX-API-DMAC7.html)
AU (1) AU766653B2 (cg-RX-API-DMAC7.html)
CA (1) CA2320962C (cg-RX-API-DMAC7.html)
DE (1) DE69943039D1 (cg-RX-API-DMAC7.html)
ES (1) ES2356595T3 (cg-RX-API-DMAC7.html)
WO (1) WO1999040928A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7217694B2 (en) * 2000-09-19 2007-05-15 The Governing Counsel Of The University Of Toronto Inhibitors of IAPP fibril formation and uses thereof
EP2123293A3 (en) 2000-12-14 2010-09-08 Amylin Pharmaceuticals, Inc. Peptide YY and petide YY agonists for treatment of metabolic disorders
EP1461068A4 (en) * 2001-11-26 2006-03-29 Protemix Corp Ltd METHOD AND COMPOSITIONS FOR NORMALIZING LIPID MIRRORS IN MIRACLE TISSUE
US20070275877A1 (en) * 2003-08-29 2007-11-29 Amylin Pharmaceuticals, Inc. Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders
RU2385878C2 (ru) * 2004-02-11 2010-04-10 Амилин Фармасьютикалз, Инк. Пептид, обладающий свойствами амилина (варианты), и его применение (варианты)
EP2718315B1 (en) * 2011-06-10 2017-12-27 Novo Nordisk A/S Pramlintide derivatives
PL2838914T3 (pl) * 2012-04-19 2017-11-30 Novo Nordisk A/S Analogi ludzkiej amyliny
BR112020002804A2 (pt) 2017-08-24 2020-07-28 Novo Nordisk A/S composição farmacêutica líquida, e, kit
IL294521A (en) 2020-02-18 2022-09-01 Novo Nordisk As glp-1 compounds and their uses

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3640042A1 (de) * 1985-12-04 1987-06-11 Sandoz Ag Neue calcitoninderivate
NL8602950A (nl) 1985-12-04 1987-07-01 Sandoz Ag Calcitonine-derivaten en werkwijzen voor het bereiden van deze derivaten en van farmaceutische preparaten die ze bevatten.
HU206890B (en) * 1986-10-13 1993-01-28 Sandoz Ag Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components
DK163689A (da) 1988-04-08 1989-10-30 Sandoz Ag Peptidderivater
US5321008A (en) 1991-01-10 1994-06-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
US5580953A (en) 1991-08-14 1996-12-03 Amylin Pharmaceuticals, Inc. Amylin antagonist peptides and uses therefor
US5506204A (en) 1991-11-19 1996-04-09 Peptech (Uk) Limited Muramyl compounds for treatment of septic shock
WO1993014408A1 (en) * 1992-01-14 1993-07-22 Amylin Pharmaceuticals, Inc. Myotonin receptors and screening methods
US5376638A (en) * 1992-09-01 1994-12-27 Amylin Pharmaceuticals, Inc. Methods for treating renin-related disorders with amylin antagonists
US5625032A (en) 1993-07-21 1997-04-29 Amylin Pharmaceuticals, Inc. Selective amylin antagonist peptides and uses therefor
WO1995007098A1 (en) 1993-09-07 1995-03-16 Amylin Pharmaceuticals, Inc. Methods for regulating gastrointestinal motility

Similar Documents

Publication Publication Date Title
EP0477885B1 (en) Parathyroid hormone derivatives
AU761652B2 (en) New peptide compounds that are analogues of the glucagon-like peptide-1 (7-37), a process for their preparation and pharmaceutical compositions containing them
Bornstein Comparative sequence studies of rat skin and tendon collagen. I. Evidence for incomplete hydroxylation of individual prolyl residues in the normal proteins
ES2302390T3 (es) Analogos de glp-1.
JP2020073481A5 (cg-RX-API-DMAC7.html)
JPS62159B2 (cg-RX-API-DMAC7.html)
JP2003522721A5 (cg-RX-API-DMAC7.html)
JPH0680079B2 (ja) ポリペプチド
WO1998052415B1 (en) Substantially pure zonulin, a physiological modulator of mammalian tight junctions
CA2066913A1 (en) Novel binding peptides
CA2270176A1 (en) Methylated, smd homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus
KR870007203A (ko) 펩타이드를 제조하는 방법
JP2023526550A (ja) Glp-2の持続型結合体の液状製剤
CA2320962A1 (en) Novel mixed amylin activity compounds
NZ198626A (en) Peptides and pharmaceutical compositions
JP2004513079A5 (cg-RX-API-DMAC7.html)
AU2010279076B2 (en) Motilin-like peptide compound having transmucosal absorbability imparted thereto
JPH09165400A (ja) 新規ペプチド
JPH051798B2 (cg-RX-API-DMAC7.html)
Isemura et al. Amino acid sequences of fragments I and II obtained by cyanogen bromide cleavage of rat serum albumin
JP2967956B2 (ja) ペプチドまたはその塩
JPH0625288A (ja) ペプチドまたはその塩
IE64494B1 (en) Cyclic grf-analogs
WO2012142706A1 (en) Growth hormone releasing factor (grf) analogs and uses thereof
US5225400A (en) Immunostimulating peptides, a process for their preparation and pharmaceutical compositions containing them